Intervention not reported
Maximum Plasma Creatine Phosphate · patients with acute coronary syndrome
1 finding from 1 review
Intervention not reported
Single trial only · patients with acute coronary syndrome
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
All‐cause mortality ‐ short‐term · Anyone diagnosed with AMI
Cells showed no clear difference in all‐cause mortality ‐ short‐term compared with no cells (moderate certainty).
1 finding from 1 review
All‐cause mortality ‐ long‐term · Anyone diagnosed with AMI
Cells showed no clear difference in all‐cause mortality ‐ long‐term compared with no cells (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · Anyone diagnosed with AMI
Cells showed no clear difference in cardiovascular mortality ‐ short‐term compared with no cells (moderate certainty).
2 findings from 1 review
Composite death, reinfarction and hospitalisation for heart failure ‐ short‐term · Anyone diagnosed with AMI
Cells showed no clear difference in composite death, reinfarction and hospitalisation for heart failure… compared with no cells (moderate certainty).
1 finding from 1 review
Composite death, reinfarction and hospitalisation for heart failure ‐ long‐term · Anyone diagnosed with AMI
Cells showed no clear difference in composite death, reinfarction and hospitalisation for heart failure… compared with no cells (moderate certainty).
1 finding from 1 review
Survival to hospital discharge · participants with bradyasystolic cardiac arrest in adults
Aminophylline showed no clear difference in survival to hospital discharge compared with placebo (moderate certainty).
2 findings from 1 review
Return of spontaneous circulation · participants with bradyasystolic cardiac arrest in adults
Aminophylline showed no clear difference in return of spontaneous circulation compared with placebo (high certainty).
2 findings from 1 review
Early administration of aminophylline: survival to hospital admission · participants with bradyasystolic cardiac arrest in adults
Aminophylline showed no clear difference in survival to admission compared with placebo (moderate certainty).
2 findings from 1 review
All‐cause mortality: Structured telephone support versus usual care · patients with heart failure
Summary of findings ‐ structured telephone support or telemonitoring probably leads to lower all‐cause mortality: Structured telephone support versus usual care compared with usual care ‐ all‐cause mortality (moderate certainty).
1 finding from 1 review
Death (all causes) · patients with heart failure
Summary of findings ‐ structured telephone support or telemonitoring probably leads to lower all‐cause mortality: Telemonitoring versus usual care compared with usual care ‐ all‐cause mortality (moderate certainty).
1 finding from 1 review
Hospitalisation (any cause) · patients with heart failure
It is very uncertain whether summary of findings ‐ structured telephone support or telemonitoring changes all‐cause hospitalisation: Structured telephone support verus usual… compared with usual care ‐ all‐cause hospitalisation (very low certainty).
2 findings from 1 review
Heart failure hospitalisation (RR) · patients with heart failure
Summary of findings ‐ structured telephone support or telemonitoring probably leads to lower CHF‐related hospitalisation: Structured telephone support versus… compared with usual care ‐ heart failure‐related hospitalisation (moderate certainty).
2 findings from 1 review
Short‐term mortality (up to 30 days) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Blood loss in first 24 hours (neonates and paediatric cases) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Red cell transfusion requirement in first 24 hours (neonates and paediatric cases) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Number of participants receiving a red cell transfusion (total) · Neonates, children and adults undergoing cardiovascular surgery
Fresh frozen plasma probably leads to higher number of patients receiving a red cell transfusion compared with no plasma (moderate certainty).
1 finding from 1 review
Measurement of prothrombin time within 2 hours of infusion · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
Resource use: need for return to theatre · Neonates, children and adults undergoing cardiovascular surgery
Fresh frozen plasma showed no clear difference in resource use: need for return to theatre compared with no plasma (moderate certainty).
1 finding from 1 review